Mid-Career Industry Fellowships - Grant ID: IM230100002
Funder
Australian Research Council
Funding Amount
$1,056,049.00
Summary
Artificial intelligence empowered multi-modal biomedical imaging. This Industry Fellowship aims to transform biomedical imaging using artificial intelligence with world-leading industry partners. The project expects to make a major advance in multi-modal Magnetic Resonance Imaging and Positron Emission Tomography image reconstruction for robust, accurate and efficient imaging. This project timely addresses industry needs with novel solutions and will establish a technology roadmap to inform and ....Artificial intelligence empowered multi-modal biomedical imaging. This Industry Fellowship aims to transform biomedical imaging using artificial intelligence with world-leading industry partners. The project expects to make a major advance in multi-modal Magnetic Resonance Imaging and Positron Emission Tomography image reconstruction for robust, accurate and efficient imaging. This project timely addresses industry needs with novel solutions and will establish a technology roadmap to inform and de-risk future research and development in image reconstruction. The project outcomes should provide benefits to Australians with cost-effective imaging and benefits to Australia's biomedical industry with well-aligned intellectual properties and training of future scientists with industry knowledge.Read moreRead less
Haemodynamic investigation of flow diverter stents for the treatment of intracranial aneurysms. This project will explore the engineering of a flow diverter, an endovascular device for the treatment of brain aneurysms. The project will determine the optimal design of new types of flow diverters, which in turn could improve the effectiveness of treatments, thus reducing the associated costs of cerebral haemorrhage and stroke.
Acoustic trapping for life science applications. Force fields can be established to move suspended cells into predefined locations using high frequency vibration; randomly dispersed cells can be brought together into clusters. This project aims to develop such technologies and will have applications in drug discovery and cell to cell interaction studies and has the future potential to promote the health of Australians.
Combined optical and electrical stimulation of auditory neurons. The bionic ear, which has now helped to improve the hearing of over 200,000 people worldwide, is a great example of Australian innovation success. This project aims to develop the fundamental technology that will underpin the next generation of these devices using a combination of infrared light and electrical signals to stimulate auditory nerves.
Complete blood fractionation using a low-cost microfluidic system. This project aims to understand particle focusing in inertial microfluidic systems to design efficient devices for cell sorting. The field of microfluidics could ultimately advance medical research but device design is primitive. Microfluidic particle separations are not thoroughly simulated before fabrication to predict performance. This project is expected to accelerate progress in design of efficient microfluidic devices. The ....Complete blood fractionation using a low-cost microfluidic system. This project aims to understand particle focusing in inertial microfluidic systems to design efficient devices for cell sorting. The field of microfluidics could ultimately advance medical research but device design is primitive. Microfluidic particle separations are not thoroughly simulated before fabrication to predict performance. This project is expected to accelerate progress in design of efficient microfluidic devices. The knowledge and models developed in this project should help design and develop a microfluidic device for efficient fractionation of complex fluids into valuable components.Read moreRead less
Understanding surface acoustic wave atomisation for pulmonary delivery of drug aerosols in personalised medicine. Delivering drugs via the lung is hampered by development costs and inadequate technology. This project will provide an understanding of atomisation in our unique respire system, enabling not only the delivery of new vaccines and drugs but also the rapid and cost effective development of new disease treatments personalised to the patient.
Wearable device design with continuous cuff-less blood pressure measurement. This project aims to develop a non-invasive, body-worn device able to monitor blood pressure (BP) continuously in real time. The project proposes new sensing techniques for blood pressure measurement based on capturing pulse transit time in the central arteries using a combination of electrical bio-impedance, electrocardiogram (ECG), and continuous wave radar. Coupled with other vital parameters including heart rate, he ....Wearable device design with continuous cuff-less blood pressure measurement. This project aims to develop a non-invasive, body-worn device able to monitor blood pressure (BP) continuously in real time. The project proposes new sensing techniques for blood pressure measurement based on capturing pulse transit time in the central arteries using a combination of electrical bio-impedance, electrocardiogram (ECG), and continuous wave radar. Coupled with other vital parameters including heart rate, heart rhythm, respiratory rate, and oxygen saturation, it is expected that the device will enable remote monitoring with wireless connectivity and with many advantages over the traditional wired monitoring methods currently used in healthcare environments and it will assist with more effective prevention, home care and treatment.Read moreRead less
Putting an end to hospital-borne infection with micronebulisation of lung-safe disinfectants. Dangerous infections are unfortunately common in hospitals, established and retransmitted via surfaces and handheld items, representing a leading contributor to death worldwide, and potentially a far more serious problem to come as antimicrobial resistance worsens. The project aims to exploit a newly discovered and unique low power nebulisation technology to nebulise a strongly antiviral, antibacterial ....Putting an end to hospital-borne infection with micronebulisation of lung-safe disinfectants. Dangerous infections are unfortunately common in hospitals, established and retransmitted via surfaces and handheld items, representing a leading contributor to death worldwide, and potentially a far more serious problem to come as antimicrobial resistance worsens. The project aims to exploit a newly discovered and unique low power nebulisation technology to nebulise a strongly antiviral, antibacterial and antifungal agent, triethylene glycol that is too viscous to do so by any other known method. Through refinement and engineering of the technology via this project, handheld and room-based continuously operating nebulisers will produce continuous microdroplet mists of these pathogen-killing agents that deposit on surfaces throughout a hospital.Read moreRead less
New techniques to detect fetal heart abnormalities. Australia’s national fetal death rate is 6.7 per one thousand births. In Australia’s Indigenous community it surges to 12.3 deaths per one thousand births. Early diagnosis (and management) of abnormal fetu.ses with cardiac defects will go a long way in reducing these numbers. The proposed technology will help set up easy-to-use systems for fetal cardiac abnormality screening and reduce fetal deaths and congenital heart disease burden in adult l ....New techniques to detect fetal heart abnormalities. Australia’s national fetal death rate is 6.7 per one thousand births. In Australia’s Indigenous community it surges to 12.3 deaths per one thousand births. Early diagnosis (and management) of abnormal fetu.ses with cardiac defects will go a long way in reducing these numbers. The proposed technology will help set up easy-to-use systems for fetal cardiac abnormality screening and reduce fetal deaths and congenital heart disease burden in adult life. This project will also provide domain trained researchers with cutting edge international academic and industry expertise.Read moreRead less
Rapid point-of-care detection of genomic variations for personalised medicine. Selecting treatment based on a person’s genetic profile can improve drug safety and efficacy, but the application is hampered by the inconvenience, slow result turnaround and high cost of current lab-based tests. Full implementation of personalised medicine in clinical practice requires a point-of-care testing system. This project aims to overcome the challenges involved in developing such a system by validating novel ....Rapid point-of-care detection of genomic variations for personalised medicine. Selecting treatment based on a person’s genetic profile can improve drug safety and efficacy, but the application is hampered by the inconvenience, slow result turnaround and high cost of current lab-based tests. Full implementation of personalised medicine in clinical practice requires a point-of-care testing system. This project aims to overcome the challenges involved in developing such a system by validating novel rapid genotyping methods and developing ultrasensitive real-time DNA detection that will be integrated on a single chip platform to facilitate a small, low cost and reliable test device. The technology will be readily adaptable to areas where prompt access to genomic information is valuable, such as disease diagnosis and risk prediction.Read moreRead less